Philogen announces its attendance at the Festival of Biologics Basel on November 10, 2021

Lisa Nadal, 3-year PhD student at Philogen, is giving a lecture entitled “A novel IL12-based immunocytokine targeting Fibroblast Activation Protein (FAP) for the treatment of cancer”

Roberto De Luca, Head of Antibody Therapeutics at Philogen, is giving a lecture entitled “Tripokin: tumor targeted delivery of IL2 potentiated by TNF”

Samuele Cazzamalli, Head of Small Molecule Therapeutics at Philogen, is giving a lecture entitled “Pan-tumoral Small Molecule-Drug Conjugates targeting Fibroblast Activation Protein in solid lesions”

Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled “Antibody-cytokine fusions directed against splice variants of fibronectin for the therapy of disseminated cancer: from discovery to Phase III clinical trials”